137 related articles for article (PubMed ID: 11683423)
1. Phenytoin-induced bone loss and its prevention with alfacalcidol or calcitriol in growing rats.
Onodera K; Takahashi A; Mayanagi H; Wakabayashi H; Kamei J; Shinoda H
Calcif Tissue Int; 2001 Aug; 69(2):109-16. PubMed ID: 11683423
[TBL] [Abstract][Full Text] [Related]
2. Effects of phenytoin and/or vitamin K2 (menatetrenone) on bone mineral density in the tibiae of growing rats.
Onodera K; Takahashi A; Sakurada S; Okano Y
Life Sci; 2002 Feb; 70(13):1533-42. PubMed ID: 11895104
[TBL] [Abstract][Full Text] [Related]
3. Effects of chronic administration of zonisamide, an antiepileptic drug, on bone mineral density and their prevention with alfacalcidol in growing rats.
Takahashi A; Onodera K; Kamei J; Sakurada S; Shinoda H; Miyazaki S; Saito T; Mayanagi H
J Pharmacol Sci; 2003 Apr; 91(4):313-8. PubMed ID: 12719660
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of alendronate and alfacalcidol on cancellous and cortical bone mass and bone mechanical properties in ovariectomized rats.
Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
Exp Anim; 2006 Jul; 55(4):357-67. PubMed ID: 16880683
[TBL] [Abstract][Full Text] [Related]
5. Effects of combined administration of alfacalcidol and risedronate on cancellous and cortical bone mass of the tibia in glucocorticoid-treated young rats.
Iwamoto J; Seki A; Takeda T; Yamada H; Sato Y; Yeh JK
Chin J Physiol; 2008 Jun; 51(3):121-8. PubMed ID: 18935906
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
[TBL] [Abstract][Full Text] [Related]
7. Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.
Reginster JY; Lecart MP; Richy F
J Rheumatol Suppl; 2005 Sep; 76():21-5. PubMed ID: 16142847
[TBL] [Abstract][Full Text] [Related]
8. Lasofoxifene (CP-336,156) protects against the age-related changes in bone mass, bone strength, and total serum cholesterol in intact aged male rats.
Ke HZ; Qi H; Chidsey-Frink KL; Crawford DT; Thompson DD
J Bone Miner Res; 2001 Apr; 16(4):765-73. PubMed ID: 11316005
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of risedronate and calcitriol on cancellous bone in rats with glucocorticoid-induced osteopenia.
Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Shen CL; Yeh JK
J Nutr Sci Vitaminol (Tokyo); 2006 Feb; 52(1):21-7. PubMed ID: 16637226
[TBL] [Abstract][Full Text] [Related]
10. Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis.
Jacobs JW; de Nijs RN; Lems WF; Geusens PP; Laan RF; Huisman AM; Algra A; Buskens E; Hofbauer LC; Oostveen AC; Bruyn GA; Dijkmans BA; Bijlsma JW
J Rheumatol; 2007 May; 34(5):1051-7. PubMed ID: 17407214
[TBL] [Abstract][Full Text] [Related]
11. [Effects of calcitriol and alfacalcidol on an osteoporosis model in rats with hepatic failure].
Yamanishi A; Ishibashi Y; Kuriyama K; Tachiiri T; Kusajima H; Kojima E; Momo K
Nihon Yakurigaku Zasshi; 1999 Jan; 113(1):55-65. PubMed ID: 10096106
[TBL] [Abstract][Full Text] [Related]
12. 1alpha-hydroxyvitamin D2 is less toxic but not bone selective relative to 1alpha-hydroxyvitamin D3 in ovariectomized rats.
Weber K; Goldberg M; Stangassinger M; Erben RG
J Bone Miner Res; 2001 Apr; 16(4):639-51. PubMed ID: 11315991
[TBL] [Abstract][Full Text] [Related]
13. Bone disease induced by phenytoin therapy: clinical and experimental study.
Moro-Alvarez MJ; Díaz Curiel M; de la Piedra C; Mariñoso ML; Carrascal MT
Eur Neurol; 2009; 62(4):219-30. PubMed ID: 19628941
[TBL] [Abstract][Full Text] [Related]
14. Alfacalcidol prevents age-related bone loss and causes an atypical pattern of bone formation in aged male rats.
Li M; Healy DR; Li Y; Simmons HA; Su M; Jee WS; Shen VW; Thompson DD
J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):22-32. PubMed ID: 15615075
[TBL] [Abstract][Full Text] [Related]
15. Influence of age on cyclosporin A-induced alterations in bone mineral metabolism in the rat in vivo.
Katz I; Li M; Joffe I; Stein B; Jacobs T; Liang XG; Ke HZ; Jee W; Epstein S
J Bone Miner Res; 1994 Jan; 9(1):59-67. PubMed ID: 8154310
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of the bone-restorative efficacy of anabolic agents in aged ovariectomized rats.
Iwaniec UT; Moore K; Rivera MF; Myers SE; Vanegas SM; Wronski TJ
Osteoporos Int; 2007 Mar; 18(3):351-62. PubMed ID: 17120182
[TBL] [Abstract][Full Text] [Related]
17. Effects of menatetrenone on the bone and serum levels of vitamin K2 (menaquinone derivatives) in osteopenia induced by phenytoin in growing rats.
Onodera K; Takahashi A; Wakabayashi H; Kamei J; Sakurada S
Nutrition; 2003 May; 19(5):446-50. PubMed ID: 12714099
[TBL] [Abstract][Full Text] [Related]
18. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
Khan MP; Mishra JS; Sharan K; Yadav M; Singh AK; Srivastava A; Kumar S; Bhaduaria S; Maurya R; Sanyal S; Chattopadhyay N
Phytomedicine; 2013 Nov; 20(14):1256-66. PubMed ID: 23928508
[TBL] [Abstract][Full Text] [Related]
19. Phenytoin and fluoride act in concert to stimulate bone formation and to increase bone volume in adult male rats.
Ohta T; Wergedal JE; Matsuyama T; Baylink DJ; Lau KH
Calcif Tissue Int; 1995 May; 56(5):390-7. PubMed ID: 7621347
[TBL] [Abstract][Full Text] [Related]
20. Human parathyroid hormone 1-34 prevents bone loss in experimental biliary cirrhosis in rats.
Dresner-Pollak R; Gabet Y; Steimatzky A; Hamdani G; Bab I; Ackerman Z; Weinreb M
Gastroenterology; 2008 Jan; 134(1):259-67. PubMed ID: 18061175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
